Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
339.9 INR | +1.16% | +9.77% | +36.15% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
May. 31 | Biocon Limited Receives Show Cause Notice from the Assistant Commissioner of Customs, Chennai | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.15% | 4.8B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.74% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon's Consolidated Net Profit Declines in Fiscal Q4